Document 0674
 DOCN  M9650674
 TI    Drug-resistant tuberculosis: mechanisms and management.
 DT    9605
 AU    Hayward CM; Herrman JL; Griffin GE; Division of Infectious Diseases, St
       George's Hospital Medical; School, London.
 SO    Br J Hosp Med. 1995 Nov 15-Dec 12;54(10):494-500. Unique Identifier :
       AIDSLINE MED/96161529
 AB    Infection with Mycobacterium tuberculosis remains a major global health
       problem and the recent outbreaks of multidrug resistant (MDR)
       tuberculosis have been a major cause for concern. An accurate picture of
       the extent of this problem is not possible because only a limited number
       of countries have reliable surveillance programmes. However, the
       experience in the USA reinforces the need for strict adherence to
       standard public health measures and good clinical practices to minimise
       the impact of MDR tuberculosis in the human immunodeficiency virus era.
 DE    Antitubercular Agents/THERAPEUTIC USE  Drug Therapy, Combination  Great
       Britain/EPIDEMIOLOGY  Human  Incidence  Population Surveillance
       Support, Non-U.S. Gov't  *Tuberculosis,
       Multidrug-Resistant/EPIDEMIOLOGY/MICROBIOLOGY/  PREVENTION & CONTROL
       *Tuberculosis, Pulmonary/EPIDEMIOLOGY/MICROBIOLOGY/PREVENTION &  CONTROL
       JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).